HC Wainwright Has Pessimistic Outlook of Balchem Q1 Earnings

Balchem Co. (NASDAQ:BCPC) – Equities research analysts at HC Wainwright decreased their Q1 2025 earnings per share estimates for shares of Balchem in a note issued to investors on Monday, February 24th. HC Wainwright analyst R. Selvaraju now expects that the basic materials company will earn $0.99 per share for the quarter, down from their prior estimate of $1.06. HC Wainwright currently has a “Buy” rating and a $190.00 target price on the stock. The consensus estimate for Balchem’s current full-year earnings is $4.64 per share. HC Wainwright also issued estimates for Balchem’s Q2 2025 earnings at $1.03 EPS, Q3 2025 earnings at $1.08 EPS, Q4 2025 earnings at $1.12 EPS, FY2025 earnings at $4.22 EPS, Q1 2026 earnings at $1.13 EPS, Q2 2026 earnings at $1.17 EPS, Q3 2026 earnings at $1.20 EPS and FY2026 earnings at $4.71 EPS.

Several other equities analysts have also recently issued reports on the company. StockNews.com cut Balchem from a “buy” rating to a “hold” rating in a report on Tuesday. Sidoti raised Balchem to a “hold” rating in a research report on Tuesday.

Balchem Price Performance

Shares of NASDAQ:BCPC opened at $172.00 on Wednesday. The firm has a market capitalization of $5.60 billion, a price-to-earnings ratio of 43.77, a price-to-earnings-growth ratio of 4.41 and a beta of 0.69. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.99 and a quick ratio of 1.16. The business’s 50 day simple moving average is $162.24 and its 200-day simple moving average is $169.48. Balchem has a 12 month low of $137.69 and a 12 month high of $186.03.

Balchem (NASDAQ:BCPC) last released its quarterly earnings data on Friday, February 21st. The basic materials company reported $1.03 EPS for the quarter, missing analysts’ consensus estimates of $1.11 by ($0.08). Balchem had a return on equity of 11.37% and a net margin of 13.47%. The company had revenue of $240.00 million for the quarter, compared to analysts’ expectations of $239.96 million.

Balchem Increases Dividend

The company also recently disclosed an annual dividend, which was paid on Friday, January 17th. Investors of record on Thursday, December 26th were paid a dividend of $0.87 per share. This is an increase from Balchem’s previous annual dividend of $0.79. The ex-dividend date of this dividend was Thursday, December 26th. This represents a dividend yield of 0.4%. Balchem’s dividend payout ratio is presently 22.14%.

Institutional Trading of Balchem

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Westside Investment Management Inc. purchased a new position in shares of Balchem during the 3rd quarter worth $27,000. Covestor Ltd increased its stake in Balchem by 93.8% in the fourth quarter. Covestor Ltd now owns 157 shares of the basic materials company’s stock valued at $26,000 after purchasing an additional 76 shares during the last quarter. R Squared Ltd acquired a new stake in Balchem in the 4th quarter worth about $29,000. Wilmington Savings Fund Society FSB purchased a new stake in Balchem in the 3rd quarter valued at about $35,000. Finally, Federated Hermes Inc. acquired a new position in shares of Balchem during the 4th quarter valued at about $33,000. 87.91% of the stock is owned by hedge funds and other institutional investors.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.